QS Investors’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$188K Sell
11,000
-200
-2% -$3.74K ﹤0.01% 1072
2021
Q1
$234K Buy
11,200
+200
+2% +$4.62K ﹤0.01% 1063
2020
Q4
$252K Hold
11,000
﹤0.01% 1050
2020
Q3
$180K Sell
11,000
-47,598
-81% -$862K ﹤0.01% 1088
2020
Q2
$794K Hold
58,598
0.01% 798
2020
Q1
$695K Sell
58,598
-1,302
-2% -$28.9K 0.01% 760
2019
Q4
$1.47M Sell
59,900
-1,050
-2% -$21.3K 0.01% 676
2019
Q3
$1.04M Sell
60,950
-90
-0.1% -$1.64K 0.01% 772
2019
Q2
$1.39M Sell
61,040
-1,250
-2% -$33.7K 0.02% 703
2019
Q1
$2M Hold
62,290
0.02% 609
2018
Q4
$1.76M Hold
62,290
0.02% 598
2018
Q3
$1.79M Hold
62,290
0.02% 646
2018
Q2
$2.33M Buy
62,290
+7
+0% +$275 0.02% 564
2018
Q1
$2.45M Sell
62,283
-3,769
-6% -$138K 0.03% 509
2017
Q4
$2.14M Sell
66,052
-511
-0.8% -$15.3K 0.02% 585
2017
Q3
$2.07M Sell
66,563
-1,387
-2% -$41.1K 0.02% 598
2017
Q2
$1.9M Hold
67,950
0.02% 608
2017
Q1
$1.17M Hold
67,950
0.01% 763
2016
Q4
$822K Hold
67,950
0.01% 795
2016
Q3
$1.08M Hold
67,950
0.01% 763
2016
Q2
$879K Hold
67,950
0.01% 792
2016
Q1
$1.29M Hold
67,950
0.01% 719
2015
Q4
$1.53M Buy
67,950
+41,284
+155% +$816K 0.01% 715
2015
Q3
$624K Buy
+26,666
New +$736K 0.01% 850

Other funds holding XENT

QS Investors's XENT Position: Q2 2021 in Review

QS Investors reduced its Intersect ENT, Inc (XENT) stake by 1.8% in Q2 2021, selling an estimated $3.74K and leaving 11,000 shares worth $188K. The position accounts for ﹤0.01% of the portfolio, ranked #1072.

QS Investors first reported a position in XENT in Q3 2015 and has held it in 24 quarters since. The position peaked at $2.45M in Q1 2018. 107 funds tracked by Wall St. Rank hold XENT as of Q2 2021.

  • QS Investors held 11,000 shares of Intersect ENT, Inc worth $188K as of Q2 2021.
  • QS Investors sold 200 Intersect ENT, Inc shares in Q2 2021, an estimated $3.74K.
  • Intersect ENT, Inc made up ﹤0.01% of QS Investors's portfolio in Q2 2021, its #1072 holding.
  • QS Investors first reported a position in Intersect ENT, Inc in Q3 2015 and has held it in 24 quarters since.
  • QS Investors's Intersect ENT, Inc position peaked at $2.45M in Q1 2018.
  • 107 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.